Provided by Tiger Trade Technology Pte. Ltd.

YieldMax JP Option Income Strategy ETF

13.89
-0.2008-1.43%
Volume:5K
Turnover:76.18K
Market Cap:48.27M
PE:- -
High:13.93
Open:13.93
Low:13.89
Close:14.09
52wk High:17.49
52wk Low:13.26
Shares:3.48M
Float Shares:3.48M
Volume Ratio:1.39
T/O Rate:0.16%
Dividend:4.38
Dividend Rate:31.53%
ROE:--
ROA:-46.62%
PB:-18.04
PE(LYR):- -

Loading ...

US Personal Injury Law Firm Morgan & Morgan Touts $1 Billion AI Investment, Plans to Sell Platform to Other Firms

Reuters
·
23 hours ago

JPMorgan Internet analysts hold analyst/industry conference call

TIPRANKS
·
23 hours ago

Anthropic Targets Wealth Management with New AI Tools and Schwab Partnership

Dow Jones
·
23 hours ago

Wall Street's Triple Decline Meets JPMorgan's Contrarian Optimism: Seize the 'Golden Dip'

Deep News
·
Yesterday

Market Chatter: JPMorgan to Launch Frontier Market Local Currency Bond Index by End-September

MT Newswires Live
·
Yesterday

ASML Examining Ways it Can Make More than 110 EUV Tools in 2028, JPMorgan Says

Reuters
·
Yesterday

S&P Global participates in a conference call with JPMorgan

TIPRANKS
·
Yesterday

Global Brokerages Expect Fed Rate Hikes After Strong Inflation Report

Reuters
·
Yesterday

BASF Mandates Banks for Planned Agricultural Business Listing

Reuters
·
Yesterday

AIB Data Centers Buys 29.4-Acre Texas Site, Adds 55 MW Contracted Power Capacity

Reuters
·
Yesterday

Oil over $100 Has JPMorgan Stock-Market Strategists Fearing a Missing Out on a Swift Decline

Dow Jones
·
Yesterday

Central Bank Marathon Ahead: Fed, BOJ, and BoE Decisions Set to Shape Global Markets This Week

Deep News
·
Yesterday

JPMorgan Chase & Co.'S Long Position in Bilibili Increases to 19.32% on Sept 9 from 17.88% - HKEX

THOMSON REUTERS
·
Yesterday

UMB Financial initiated with a Neutral at UBS

TIPRANKS
·
Yesterday

JPMorgan Highlights Strong Overall Survival Data from Akeso's HARMONi-2 Trial, Reaffirms Overweight Rating

Stock News
·
Yesterday

Fed Hike Looming, Is The US Bull Market At Risk? Goldman Pushes Back: Earnings Growth Is What Matters

Analyst Calls
·
Yesterday

Bank of Japan Approaches Critical Policy Crossroads

Deep News
·
Yesterday

JPMorgan Highlights Encouraging Lung Cancer Data for Hansoh Pharma's B7-H3 ADC, Reaffirms Overweight Rating

Stock News
·
Yesterday

JPMorgan Highlights GenScript's Post-Placement Strength, Reaffirms Overweight Stance

Stock News
·
Yesterday

Genscript Biotech Jumps Over 5% in Afternoon Trade; JPMorgan Highlights Persistent Investor Interest in AIDD Segment

Deep News
·
Yesterday